Comparing overall survival of patients with metastatic uveal melanoma by sequence of Tebentafusp versus combination immune checkpoint inhibitors.

被引：0
|
作者：
Shikdar, Sufana
Day, Silas
Ikeguchi, Alexandra
Ying, Yuan
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Med Ctr, Oklahoma City, OK USA
[3] Stephenson Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21505
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of immune checkpoint inhibitors in patients with metastatic uveal melanoma treated with tebentafusp
    Koch, E. C.
    Ceballos, D. P. Arteaga
    Vilbert, M.
    Lajkosz, K.
    Muniz, T. Pimentel
    Hirsch, I.
    Ribeiro, M. F. Silva Almeida
    Mantle, L.
    Anczurowski, M.
    Hogg, D.
    Saibil, S.
    Spreafico, A.
    Krema, H.
    Butler, M. O.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S928 - S928
  • [2] Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
    Nathan, Paul
    Hassel, Jessica C.
    Rutkowski, Piotr
    Baurain, Jean-Francois
    Butler, Marcus O.
    Schlaak, Max
    Sullivan, Ryan J.
    Ochsenreither, Sebastian
    Dummer, Reinhard
    Kirkwood, John M.
    Joshua, Anthony M.
    Sacco, Joseph J.
    Shoushtari, Alexander N.
    Orloff, Marlana
    Piulats, Josep M.
    Milhem, Mohammed
    Salama, April K. S.
    Curti, Brendan
    Demidov, Lev
    Gastaud, Lauris
    Mauch, Cornelia
    Yushak, Melinda
    Carvajal, Richard D.
    Hamid, Omid
    Abdullah, Shaad E.
    Holland, Chris
    Goodall, Howard
    Piperno-Neumann, Sophie
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (13): : 1196 - 1206
  • [3] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
    Dimitriou, Florentia
    Orloff, Marlana M.
    Hein, Erica C. Koch
    Cheng, Phil F.
    Hughes, Isaac F.
    Simeone, Ester
    Montazeri, Kamaneh
    Grover, Piyush
    Mehmi, Inderjit
    Gerard, Camille L.
    Gaudy-Marqueste, Caroline
    Grob, Jean-Jacques
    Michielin, Olivier
    Hamid, Omid
    V. Long, Georgina
    Sullivan, Ryan
    Kapiteijn, Ellen
    Johnson, Douglas B.
    Ascierto, Paolo A.
    Joshua, Anthony M.
    Carvajalh, Richard D.
    Butler, Marcus O.
    Hasselu, Jessica C.
    Dummer, Reinhard
    EUROPEAN JOURNAL OF CANCER, 2025, 214
  • [5] Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
    Hassel, Jessica C.
    Piperno-Neumann, Sophie
    Rutkowski, Piotr
    Baurain, Jean-Francois
    Schlaak, Max
    Butler, Marcus O.
    Sullivan, Ryan J.
    Dummer, Reinhard
    Kirkwood, John M.
    Orloff, Marlana
    Sacco, Joseph J.
    Ochsenreither, Sebastian
    Joshua, Anthony M.
    Gastaud, Lauris
    Curti, Brendan
    Piulats, Josep M.
    Salama, April K. S.
    Shoushtari, Alexander N.
    Demidov, Lev
    Milhem, Mohammed
    Chmielowski, Bartosz
    Kim, Kevin B.
    Carvajal, Richard D.
    Hamid, Omid
    Collins, Laura
    Ranade, Koustubh
    Holland, Chris
    Pfeiffer, Constance
    Nathan, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2256 - 2266
  • [6] Immune Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
    Kuo, J. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [7] Overall survival in patients who received checkpoint inhibitors after completing tebentafusp in a phase 3 randomized trial of first-line metastatic uveal melanoma.
    Orloff, Marlana
    Carvajal, Richard D.
    Shoushtari, Alexander Noor
    Sacco, Joseph J.
    Schlaak, Max
    Watkins, Claire
    Abdullah, Shaad Essa
    Goodall, Howard
    Butler, Marcus O.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Determinants of overall survival in patients with metastatic uveal melanoma
    Demkowicz, Patrick
    Pointdujour-Lim, Renelle
    Miguez, Sofia
    Lee, Yesung
    Jones, Bailey S. C. L.
    Barker, Christopher A.
    Bosenberg, Marcus
    Abramson, David H.
    Shoushtari, Alexander N.
    Kluger, Harriet
    Francis, Jasmine H.
    Sznol, Mario
    Bakhoum, Mathieu F.
    CANCER, 2023, 129 (20) : 3275 - 3286
  • [9] Overall survival and safety of tebentafusp as potential treatment for patients with uveal melanoma: a systematic review
    Santoso, K. Aurelia
    Kosayuz, S.
    Atmaja, W. Surya
    Amalia, A. Irviani Ukhti
    Subroto, D. Ravinder Theodeus
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1331 - S1331
  • [10] Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
    Yamada, Kayoko
    Takeuchi, Masaki
    Fukumoto, Takeshi
    Suzuki, Minako
    Kato, Ai
    Mizuki, Yuki
    Yamada, Norihiro
    Kaneko, Takeshi
    Mizuki, Nobuhisa
    Horita, Nobuyuki
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345